Go to content
UBS Group AG - Redcare Pharmacy N.V. - Venlo

UBS Group AG - Redcare Pharmacy N.V. - Venlo

Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.

Date of transaction 29 sep 2020
Person obliged to notify UBS Group AG
Issuing institution Redcare Pharmacy N.V.
Registration Chamber of Commerce 63986981
Place of residence Venlo

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Type of shareConverteerbare obligatieNumber of shares164.930,00Number of voting rights164.930,00Capital interestPotentieelVoting rightsPotentieelManner of disposalMiddellijk
(UBS AG)
SettlementFysieke levering
Type of shareAandeel aan toonderNumber of shares112.438,00Number of voting rights112.438,00Capital interestReëelVoting rightsReëelManner of disposalMiddellijk
(UBS Asset Management (Deutschland) GmbH, UBS Asset Management (UK) Limited, UBS (France) SA, UBS Asset Management Trust Company, UBS Bank (Canada), UBS Fund Management (Luxembourg) S.A., UBS Fund Management (Switzerland) AG, UBS Switzerland AG, UBS AG)
SettlementFysieke levering
Type of shareAandeel aan toonderNumber of shares556.166,00Number of voting rights556.166,00Capital interestPotentieelVoting rightsPotentieelManner of disposalMiddellijk
(UBS AG, UBS Switzerland AG)
SettlementFysieke levering
Type of shareEquity SwapNumber of shares271.521,00Number of voting rights271.521,00Capital interestPotentieelVoting rightsPotentieelManner of disposalMiddellijk
(UBS AG)
SettlementIn contanten

Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
TypeKapitaalbelangTotal holding7,35 %Directly real0,00 %Directly potential0,00 %Indirectly real0,75 %Indirectly potential6,60 %
TypeStemrechtTotal holding7,35 %Directly real0,00 %Directly potential0,00 %Indirectly real0,75 %Indirectly potential6,60 %

Date last update: 03 August 2025